Ligand validation:6GH7

EYW: 5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-[(3~{R})-pyrrolidin-3-yl]pentanamide

EYW is a Ligand Of Interest in 6GH7 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GH7_EYW_A_201	97%	38%	0.071	0.986	0.86	1.64	-	7	0	0	100%	1
6GH7_EYW_B_201	96%	46%	0.076	0.986	0.89	1.21	-	4	0	0	100%	1
6GH7_EYW_C_201	96%	38%	0.077	0.985	1.17	1.34	2	4	0	0	100%	1
6GH7_EYW_D_201	96%	31%	0.076	0.983	1.24	1.64	3	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.